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Observations from the field and experimental evidence suggest that different strains of infectious salmon anaemia
virus (ISAV) can induce disease of varying severity in Atlantic salmon. Variation in host mortality and dissemination
of ISAV isolates with high and low virulence was investigated using immersion challenge; from which mortality,
pathological, immunohistochemical and preliminary molecular results have been previously published. Here,
real-time RT-PCR analysis and statistical modelling have been used to further investigate variation in virus load and
the response of four select immune genes. Expression of type I and II interferon (IFN), Mx and γIFN induced protein
(γIP) to high and low pathogenic virus infection were examined in gill, heart and anterior kidney. In addition, a
novel RNA species-specific assay targeting individual RNA types was used to investigate the separate viral processes
of transcription and replication. Unexpectedly, the low virulent ISAV (LVI) replicated and transcribed more rapidly in
the gills compared to the highly virulent virus (HVI). Subsequently LVI was able to disseminate to the internal organs
more quickly and induced a more rapid systemic immune response in the host that may have offered some protection.
Contrary to this, HVI initially progressed more slowly in the gills resulting in a slower generalised infection. However HVI
ultimately reached a higher viral load and induced a greater mortality.Introduction
Infectious salmon anaemia virus (ISAV) is an aquatic or-
thomyxovirus that infects Atlantic salmon. The virus
can cause serious disease problems resulting in substan-
tial financial implications for the aquaculture industry.
Infectious salmon anaemia (ISA) has occurred annually
in Norway [1] since its discovery in 1984 [2] and has
also been reported in North America [3-5], Scotland
[6,7], Faroe Islands [8,9] and Chile [10]. ISAV is envel-
oped and possesses a genome of 8 negative-sense single-
stranded RNA segments, coding for at least 10 proteins,
similar to that of influenza virus [11,12]. Segments 1–4
produce the proteins that comprise the viral ribonucleo-
protein core. Segments 5 and 6 encode the fusion (F)
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unless otherwise stated.glycoproteins respectively. Segment 7 possesses two open
reading frames (ORFs), the first of which is thought to
produce a minor or non-structural protein (NS) [16] that
interferes with interferon (IFN) and IFN induced systems
[17,18]. The second ORF, generated via splicing, is be-
lieved to encode the nuclear export protein (NEP) [19].
Segment 8 also contains two ORFs; ORF1 encodes the
major structural matrix (M) protein [14,16] and ORF2 is
believed to produce a minor structural protein also with
IFN antagonising activity [17]. The M protein is the most
abundant protein in the virion [20] and therefore RNA of
this segment is readily targeted in diagnostic tests [21].
The pathogenicity of ISAV is a multifactorial trait
dependent on the function of viral proteins, interactions
with host immune responses as well as various environ-
mental factors. Little is known regarding the specific
interplay of these aspects and how they influence ISAV
infection. Nevertheless there are multiple reports thatal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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lence and associated mortality [22-26]. A deletion within
the highly polymorphic region (HPR) of segment 6 has
been suggested to be an important virulence marker
[25,27]. All pathogenic strains reported to date contain
an HPR deletion with respect to the putatively ancestral,
non-virulent HPR0 virus [9,28]. In addition, substitu-
tions and insertions adjacent to the putative cleavage site
in the F protein have also been linked to virulence
[27,29]. However, even isolates with identical HPR and F
protein sequences have shown variation in virulence
[25,27] indicating additional factors are also important.
Vertebrate nucleated cells rapidly secrete the cytokine
molecules interferon (IFN) in response to viral infection.
In turn, IFNs activate complex signalling pathways indu-
cing the expression of hundreds of direct and indirect
antiviral genes [for review see [30,31]]. In fish, both the
Type I and Type II IFN systems are now known to be
imperative in the innate and adaptive antiviral responses
respectively [31,32]. ISAV is a potent inducer of immune
genes yet the response offers little protection [25,33,34].
Intraperitoneal injection of a highly virulent ISAV indi-
cated significant monophasic induction of several im-
mune genes in kidney on day 6 post-infection, followed
by increased virus production and high mortality [33].
The antiviral protein Mx has become a direct indicator
of the innate Type I IFN response, induced by IFNs α
and β in a variety of cell types. Similarly, the IFNγ-
induced protein (γIP) gene can be used as an indicator
of the adaptive Type II IFN response, stimulated by γIFN
specifically in immune cells. The expression of these
interferon stimulated genes (ISGs) as induced products
of each system showed both the innate and adaptive re-
sponses were stimulated concurrently by ISAV injection
[33]. More recently, cell cultures infected with ISAV of
high or low virulence have indicated variations in im-
mune response between strains [35,36].
The present study utilises an immersion infection of
Atlantic salmon with two ISAV strains previously classed
as low (LVI) and high virulence (HVI) [23,37]. The mor-
tality, pathology, immunohistochemistry (IHC) and ini-
tial virus segment 8 qPCR results observed following the
challenge are presented in McBeath et al. [37]. Here, the
molecular results are analysed in more detail using stat-
istical modelling of the qPCR data of viral segments 7
and 8 obtained from gill, heart and anterior kidney sam-
ples. The separate viral processes of replication and tran-
scription were also investigated individually for both
viruses using novel RNA species-specific assays based on
a recently published method [38]. In addition, the ex-
pression levels of four host immune markers were also
monitored and statistically analysed to determine if in-
fection with LVI or HVI had variable effects on the im-
mune system. Ultimately, LVI was shown to replicatemore rapidly in the gills resulting in more rapid dissem-
ination and immune response throughout the host, yet
HVI reached higher viral loads, causing a more serious
infection and inducing greater mortality. The results of
this study contribute to our understanding of the patho-
genesis of this important pathogen in Atlantic salmon
aquaculture.
Materials and methods
Virus propagation, immersion challenge and organ
sampling
Details regarding the virus production, infection challenge
and organ sampling procedure have been described previ-
ously [37]. Briefly, fish were challenged by immersion with
either 104 TCID50 of highly virulent ISAV Glesvær 2/90
(HVI) or low virulent Can/F679/99 (LVI), or mock-
infected with virus-free cell culture medium as uninfected
negative controls. After 2 h, fish were transferred to
sampling tanks (n = 75) or to observation tanks where
cumulative mortalities for each treatment were observed
(n = 20). Four fish were sampled 6 h post infection (pi)
and on days 1 to 8, 10, 12, 14, 19 and 23 pi from each
challenge group. Organ samples from gill, heart, and
anterior-kidney, were collected in 1 mL RNAlater (Qiagen)
and stored at −80 °C.
Viral and immune gene expression real-time RT-PCR
RNA was extracted from 5 mg organ samples (gill, heart,
anterior kidney) using the QIAsymphony® RNA robotic
system (Qiagen) according to the manufacturers’ proto-
col and eluted in 100 μL RNase-free dH2O. The RNA
was reverse transcribed to cDNA using the TaqMan® Re-
verse Transcription Reagents kit (Life Technologies, UK)
with oligo-d(T)16 as described previously [33] using a
20 μL total reaction volume. Real-time RT-PCR assays
were performed as described in McBeath et al. [37]. Pri-
mer and probe sequences (Additional file 1) for the as-
says targeting viral gene (no differentiation of ORFs in
either assay) segments 7 (seg7) and 8 (seg8) from both
European and North-American genogroups, immune
markers Type I (α1 and α2), Type II interferon (IFN),
Mx, γIFN-induced protein (γIP) and endogenous control
elongation factor 1α (ELF), have been described previ-
ously [21,33]. Absolute quantitation of transcripts was
carried out. The cycle crossing point (Cp) values were
converted into expression values normalised against the
reference gene, ELF, using the statistical standard curve
method to produce relative expression ratios [39].
Statistical analysis
The analysis focussed on modelling the scale of virus loads
and immune responses for each ISAV isolate throughout
the experiment. Statistical analyses were performed within
the R statistical environment version 2.15.2 [40].
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log10, converting the analysis into an evaluation of the
variation in the scale of detectable expression for defined
genes associated with two ISAV strains over time. The
distributions of the transformed observations for each
gene-strain-time combination are also more satisfactory
approximations of the normal distribution. A prelimin-
ary inspection of the transformed observations suggested
that there were differences in the dispersion of the
scaled values at different times, and weights comprising
the reciprocal of the variance for each strain-time com-
bination were therefore calculated. These weights were
used for the modelling of the changes in the scale of de-
tectable gene expression for each strain over time using
a locally-weighted running-line smoother [41]. Predicted
values with their 95% confidence intervals (CI) were
plotted. Plots exhibiting minimal overlap of CI for the
two strains indicate differences in the trajectory of de-
tectable expression for that gene over time between the
two strains. A more formal evaluation of differences be-
tween strains was carried out by estimating the reduc-
tion in the residual sum of squares of nested linear
models [42] describing gene expression on the potential
explanatory variables of strain and time; p-values of ≤ 0.05
were categorised as statistically significant.
The association between the difference in the level of
expression of the immunological markers (e.g. Mx) of
the two strains with the difference in the load of the two
strains (evaluated using both the segment 7 and segment
8) was evaluated for each tissue using Spearman’s rank
correlation coefficient (rs) [43]. The statistical signifi-
cance of associations is indicated by “star value” (*0.01 <
p ≤ 0.05, **0.001 < p ≤ 0.01, ***p ≤ 0.001).
RNA species specific real-time RT-PCR
RNA species specific reverse transcription (RT) was per-
formed as described previously [38] using tagged primers
for mRNA and cRNA (Additional file 1). Reverse tran-
scription was performed at 65 °C using the Thermoscript
RT kit (Life Technologies) according to manufacturers’
protocols.
Real-time PCR was carried out using SensiFAST Sybr
no-rox Master Mix (Bioline) and primer pairs consisting
of one primer specific to the tag portion of the RT-
tagged primers and the other specific to the appropriate
viral sequence (Additional file 1). Reactions consisted of
1 × SensiFAST Sybr no-rox Master Mix, 10 μM each pri-
mer, 1 μL cDNA template in a 20 μL volume and were
subjected to a 95 °C for 2 min pre-incubation, 45 cycles
of 95 °C for 5 s, 62 °C for 10 s, 72 °C for 10 s, followed
by melting curve analysis (95 °C for 5 s, 65 °C for 1 min,
slow heating to 97 °C and cooling at 40 °C for 30 s)
using a Roche Lightcycler LC480. The cycle crossing
point (Cp) values were cross checked with melt curvedata and samples were deemed positive if the melt curve
temperature was within ± 0.5 °C of the expected value.
Samples with no Cp value or a Cp value correlated with
an incorrect melt curve temperature (i.e. indication of
non-specificity) were classed as negative. Samples with
dual melt curves were classed as positive if one was at
the correct temperature. Due to the complication of
non-specificity, no attempt was made to quantify the dif-
ferent RNA types.
Results
Experimental infection and mortality
In fish infected with HVI, mortality began on day 13 pi
and the cumulative mortality reached 100% by day 23 pi.
In the LVI group, mortality began on day 17 pi and cu-
mulative mortality reached 20% by day 23 pi. All dead
fish tested positive in kidney for ISAV segment 8 by real-
time PCR. No mortality was observed in the uninfected
negative control fish. Further details of the above results
including pathology and immunohistochemistry (IHC)
are presented in McBeath et al. [37].
Viral kinetics profile by detection of ISAV segment 8
All infected fish tested positive for segment 8 in the gills
at every time point. In heart, no virus was detected at
6 h pi, 2/4 fish tested positive for LVI and 1/4 for HVI
on day 1 pi. After 2 days, heart was positive in 3/4 fish
infected with LVI and 2/4 infected with HVI. Kidney
was also negative for segment 8 until day 2 pi when the
LVI was detected in all 4 fish and HVI was detected in
2/4 fish. Thereafter from day 3 pi, both viruses were de-
tected in all organ samples. Statistical modelling indi-
cates that the time course of the 2 strains, as indicated
by detection of segment 8, differ (p ≤ 0.05) for all 3 or-
gans (Figure 1). This was most apparent in the early
stages of the infection up to day 8 and especially notable
in the gills (Figure 1A) during the first 4 days pi. Follow-
ing day 8 pi, the LVI load almost stabilised in compari-
son to the HVI load which continued to increase further
up to day 15 pi. All uninfected control fish were negative
for ISAV.
RNA species specific analysis of segment 8
The assays targeting RNA species corresponding specific-
ally to the replication (cRNA) and transcription (mRNA)
processes provided further evidence the LVI had success-
fully entered and replicated in the gills early in infection
(Table 1). The results also suggest HVI has a slower up-
take and/or entry into the gills and therefore progresses
more slowly into generalised infection. In the LVI group,
mRNA was detected in all fish (gills) at day 1 pi and there-
after until experimental end. In comparison, HVI mRNA
was not first detected in gills until day 4 pi (in 3 fish)
which correlated with the first large increase in HVI load
Figure 1 Statistical modelling of ISAV segment 8. Statistical modelling of viral segment 8 total RNA load profiles of high virulent (dashed line)
and low virulent (solid line) strains measured by real-time RT-PCR from gill (A), anterior kidney (B) and heart (C) tissues post-immersion infection
at Day 0. Dotted lines indicate 95% confidence intervals.
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earlier in the gills than in the HVI group, although there
was increased variation at the individual level in the latter.
The difference in mRNA and cRNA production between
strains was less pronounced in the kidney and the heart.
In kidney, mRNA of both ISAV strains was detected at
day 3 pi, however the number of positive individuals
remained variable in the HVI group until day 7 pi. The
first detection of cRNA in the kidney of the LVI group
was in 1 fish on day 3 pi, followed by 3 fish on day 4 pi.The HVI cRNA was first detected in the kidney from 3
fish on day 4 pi (on days 5 and 6 also). In heart, the first
mRNA detections for both viruses were from single fish
on days 2 and 4 respectively, prior to all 4 fish on days 4
and 7 respectively. The first cRNA detections in heart oc-
curred in 1 fish on day 3 pi in the LVI group and in 2 fish
on day 4 in the HVI group.
As expected, the Cp values indicated cRNA was present
in lower amounts than mRNA [38,44]. Cross-checking Cp
results with melt curve data indicated non-specificity
Table 1 RNA strand specific real-time RT-PCR
Gill mRNA Gill cRNA Kidney mRNA Kidney cRNA Heart mRNA Heart cRNA
Day LVI HVI LVI HVI LVI HVI LVI HVI LVI HVI LVI HVI
0.25 0 0 0 0 0 0 0 0 na na na na
1 4 0 1 0 0 0 0 1 0 0 0 0
2 4 0 2 0 0 0 0 0 1 0 0 0
3 4 0 3 1 4 2 1 0 3 0 1 0
4 4 3 2 1 4 4 3 3 4 1 2 2
5 4 3 3 2 4 3 4 3 4 2 4 3
6 4 4 4 2 4 3 4 3 4 3 4 3
7 4 4 4 3 4 4 4 4 4 4 4 4
8 4 4 4 2 4 4 4 4 na na na na
10-23 4 4 4 4 4 4 4 4 na na na na
Number of fish (max. = 4) testing positive for mRNA or cRNA of low virulent (LVI) or highly virulent (HVI) virus using RNA strand specific real-time RT-PCR analysis
of gill, anterior kidney and heart. na = not applicable.
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were low (seg8 Cp > 32), as discussed previously [38].
Contrary to this, the cRNA assay was more specific, even
at very low levels (seg8 Cp > 38) (data not shown).Immune gene expression
The expression of four immune markers, Type I and II
IFN, Mx and γIP, was measured in gills, heart and anter-
ior kidney to provide information on both innate and
adaptive immune responses upon infection with the two
different ISAV strains. All immune genes in infected fish
were strongly up-regulated in comparison to the nega-
tive control fish throughout the experiment (Table 2).
The maximum increase in transcript levels for all four
immune gene markers to both ISAV strains was higher
in kidney and heart compared to gills. The highest max-
imum increase was observed for Type II IFN in kidney.
Statistical modelling indicates that the time course of ex-
pression for all four genes differ between the two strains
(p ≤ 0.05) in gill (Figure 2), anterior kidney (Figure 3)
and heart (Figure 4) indicating a differential immuno-
logical host response to the two viruses. In all cases, the
immune genes were stimulated significantly more in the
LVI group than the HVI group up to day 7 or 8 pi. InTable 2 Fold increase in expression of immune genes
Gill Kidney
Gene LVI HVI Control LVI
Type I IFN 7.7 10.4 2.7 49.6
Mx 71.6 63 1.4 213.4
Type II IFN 30.2 47 5.9 1443.2
gIP 93.2 54 2.3 242.5
Fold increase from 6 h to the maximum peak of immune gene expression (on any
high (HVI) virulence, or cell culture media to serve as negative controls. Figures in bcontrast, after day 8, the immune genes were expressed
at higher levels in the HVI fish.
Segment 8 and immune gene correlation analysis
The associations between the difference in virus segment
8 of the low and the highly virulent viruses and the dif-
ference in immune gene expression response to each
strain were investigated using correlation. The rationale
for this is that a positive association between an increas-
ing difference in load between the two strains and an in-
creasing immune response is indicative of a possible
causal relationship between viral load and immune re-
sponse. Association of the differences between the seg-
ment 8 viral load and the expression of all immune
genes in the gill and heart for both LVI and HVI
(Table 3) were observed (p ≤ 0.05), indicating an associ-
ation between viral load as measured by segment 8 RNA
quantity and immune gene expression in these organs.
Segment 7
Expression profiles for genomic segment 7 in gill, kidney
and heart (Figure 5) were similar overall to those of seg-
ment 8, although a higher quantity of segment 7 was
produced by LVI than HVI up to day 8 pi. This wasHeart
HVI Control LVI HVI Control
24.6 2.4 23.6 100.5 1.8
100 2.9 257.2 271.9 2.6
485 6.4 394.5 197.9 7.6
255 4.1 290.7 424.3 9.8
given day) post-infection (pi) for fish infected with ISAV of either low (LVI) or
old indicate the highest fold-induction for each gene in each organ.
Figure 2 Statistical modelling of immune genes in gill. Statistical modelling of 4 immune marker expression profiles, Type I IFN (A), Mx (B),
Type II IFN (C) and γIP (D) in gills of fish infected with high virulent (dashed line) or low virulent (solid line) strains measured by real-time RT-PCR.
Dotted lines indicate 95% confidence intervals.
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ments for each strain (Additional file 2). Following day 8
pi, unlike segment 8, there was little difference between
the two viruses with regards to segment 7 RNA produc-
tion as indicated by overlapping confidence intervals. In
contrast to the results for segment 8, there was no evi-
dence of an association in differences between the seg-
ment 7 viral loads and differences in immune response
for gill and heart, although positive correlation (p ≤ 0.05)
was observed in kidney (Table 3).Discussion
In the present study, organs from fish infected with low
virulent ISAV (LVI) exhibited a higher viral load in the
first 8 days of the infection compared to the highly viru-
lent virus (HVI). This was most prominent in the gills
during the first 4 days post-infection. The rapid increase
in LVI segment 8 RNA load suggests the occurrence of a
fast primary replication phase in the gill. The RNA spe-
cies specific assays provided further support for this, in-
dicating the LVI successfully gained fast entry to host
Figure 3 Statistical modelling of immune genes in kidney. Statistical modelling of 4 immune marker expression profiles, Type I IFN (A), Mx
(B), Type II IFN (C) and γIP (D) in anterior kidney of fish infected with high virulent (dashed line) or low virulent (solid line) strains measured by
real-time PCR. Dotted lines indicate 95% confidence intervals.
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ing in this early stage of infection. All four immune
genes, representing both Type I and Type II IFN systems
and two products thereof, were significantly differentially
expressed when comparing the two ISAV isolates. This
suggested differences in the host response towards the
two virus infections. Statistical correlations provided
further evidence suggesting a causal link between virus
production (as measured by segment 8 RNA) and up-regulation of the studied immune genes in the gill and
heart.
In an immersion challenge, all mucosal surfaces, in-
cluding gill, skin, eye and gut, are possible entry points
for microbial infections. The gills have previously been
suggested as the main entry port for ISAV [45]. However
fin and skin have both been implicated as important
entry points for viral haemorrhagic septicaemia (VHSV),
infectious haematopoietic necrosis virus (IHNV) and koi
Figure 4 Statistical modelling of immune genes in heart. Statistical modelling of 4 immune marker expression profiles, Type I IFN (A), Mx (B),
Type II IFN (C) and γIP (D) in heart of fish infected with high virulent (dashed line) or low virulent (solid line) strains measured by real-time RT-PCR.
Dotted lines indicate 95% confidence intervals.
Table 3 Correlation analysis
Segment 8 Segment 7
Immune gene Gill Kidney Heart Gill Kidney Heart
Mx 0.75** 0.9*** 0.9*** 0.23 0.72** 0.12
γIP 0.61* 0.43 0.96*** −0.002 0.46 0.12
Type I IFN 0.61* 0.43 0.86*** −0.002 0.56* −0.002
Type II IFN 0.82*** 0.55* 0.78** 0.49 0.56* 0.2
Correlation coefficients (rs) for differences between strains with respect to virus
burden and immune response. (*0.01 < p ≤ 0.05, **0.001 < p ≤ 0.01, ***p ≤ 0.001).
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trial using the same HVI as the present study observed a
relatively low level of infection in the gills, however few
sampling points were used [34]. The currently presented
viral load kinetics, backed up by the assays directly tar-
geting cRNA and mRNA, suggest the presence of an
early primary replication phase for the LVI in the gills,
not observed for the HVI. Detection of both viruses in
all fish at 6 h pi by seg8 real-time RT-PCR indicated
rapid uptake of both viruses to the gills from the water.
However, only the LVI amount displayed an early
Figure 5 Statistical modelling of ISAV segment 7. Statistical modelling of viral segment 7 total RNA load profiles of high virulent (dashed line)
and low virulent (solid line) strains measured by real-time RT-PCR from gill (A), anterior kidney (B) and heart (C) tissues. Dotted lines indicate 95%
confidence intervals.
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the rapid production of mRNA in the time points that
follow. The replicative intermediate, cRNA, was also de-
tected in some fish from day 1. As expected this was at
much lower levels throughout the experiment [38,44].
Therefore the production of cRNA had a negligible ef-
fect on the overall viral load compared to increasing
mRNA production and accumulating genome (vRNA)
from nascent virions. The subsequent effect of this early
virus multiplication was clearly visible in the kidney andheart, where LVI was consistently detected in greater
quantities each day up until day 8 pi. The early LVI rep-
lication (as indicated by the specific detection of the
replicative intermediate cRNA) and accumulation of
nascent virus particles in the gills, prior to dissemin-
ation, probably accounts for this. Interestingly, the puta-
tively non-virulent ISAV HPR0 is primarily associated
with detection in the gills only [9,49]. The gill results
suggest HVI progresses more slowly into a generalised
infection. However, the fact that HVI may utilise an
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not be excluded.
Virus virulence is a multifunctional trait and replica-
tion efficiency is one factor that has been associated with
increased virulence. A study into the differential viru-
lence mechanisms of two strains of IHNV of high or low
virulence in salmonid fish was shown to be linked with
faster in vivo kinetics and replication of the highly viru-
lent virus [50,51]. Early innate host immune response
was demonstrated to play a critical role and it was pro-
posed that the lag in immune system stimulation might
give the faster replicating highly virulent virus enough
time to reach a threshold and outrun the host antiviral
response [51]. In addition to the replication advantage, it
was also established that the highly virulent IHNV had
an advantage at the entry stage of the infection cycle,
when data from immersion and IP-injection experiments
were compared [52]. Contrary to this, investigations on
simian immunodeficiency virus (SIV) have suggested
high replication rates of the natural virus do not corres-
pond with increased virulence [53]. In the present study
following immersion challenge, whilst the LVI rapidly
gained entry to gill cells and replicated immediately, it
ultimately reached a lower peak viral load than the HVI
and caused a lower mortality. We could argue this pro-
vides LVI with an evolutionary advantage over HVI. Rep-
lication to relatively high levels without killing all the
available hosts may allow the virus to persist in a popu-
lation and potentially spread further. However, further
information on virus shedding rates is required to inves-
tigate this. Our data suggests that the LVI has an advan-
tage at the entry stage in gills and also exhibited a
higher replication rate during the early stages of infec-
tion. This finding agrees with previous experimental data
demonstrating slower replication of a high pathogenic
ISAV compared to a low pathogenic ISAV in Atlantic
Salmon Kidney (ASK) cells at 20 °C [35]. The reason for
apparent faster replication of LVI at early time points re-
mains unknown, but could be due to enhanced viral
RNA-dependant RNA polymerase (RdRp) activity. This
activity could also be in conjunction with differential
properties of the viral glycoproteins, such as more effi-
cient particle attachment or membrane fusion, as dem-
onstrated for highly pathogenic influenza A viruses
[54,55]. At present, functional information on ISAV
RdRp’s, and on the links between RdRp’s and surface
proteins is limited.
The significant up-regulation of all four immune genes
showed both LVI and HVI effectively stimulated the in-
nate and adaptive immune systems. The response to
both viruses was substantial and sustained. It was evident
LVI disseminated more rapidly due to its replication at the
earlier stages of infection, thus triggering an earlier sys-
temic IFN-mediated immune response compared to thatof HVI. Infection of TO cells with ISAV of low and high
virulence suggested replication was a requirement for in-
duction of immune genes [36]. The generation of dsRNA
is a pivotal part of the replication process for many ssRNA
viruses and longer stretches of dsRNA are key indicators
of viral invasion to a cell [56]. In the present study, the de-
tection of the replicative intermediary cRNA early in the
gills signals its presence. Cells detect viral RNA and pro-
teins via pathogen associated molecular pattern (PAMP)
receptors, which in turn stimulate interferons and the
antiviral response [32,57]. In this study, the more rapid
systemic response induced by LVI might have provided a
sufficient level of protection in a higher number of hosts,
preventing this strain from reaching the damaging higher
viral loads observed for HVI. In the latter half of the trial
the immune genes of the HVI infected fish were up-
regulated more in comparison to those of the LVI infected
fish. Interferon responses to viral infection are usually
transient and self-limited to avoid a prolonged anti-viral
state which in itself can be detrimental to the host and
interfere with haematopoiesis [57,58]. Indeed, the vast in-
duction of cytokines and chemokines, generating a “cyto-
kine storm” and overwhelming inflammatory responses,
have been linked to highly pathogenic influenza virus
pathogenesis [57,59,60]. The over-activation of IFNβ and
tumour necrosis factor–α (TNFα) creates a powerful pro-
inflammatory response compared to that of low patho-
genic influenza viruses, tipping the balance of the response
towards inflammation, contributing to tissue damage [61].
The possibility that the increased mortality caused by
HVI, which coincided with high expression of immune
markers was caused by similar immune mechanisms
should not be excluded. This study only focussed on a
very small aspect of the immune response, therefore a
more in-depth analysis of a greater number of immune re-
sponse genes in immersion challenged fish would be ad-
vantageous. What is clear from the present study, the
immune response was sufficient to limit the infection by
LVI while ineffectual at preventing HVI instigating a pro-
gressive infection causing an eventual fatal outcome.
RNA viruses have evolved diverse strategies to coun-
teract and evade the host immune system. The influenza
virus NS1 protein for example, is the primary antagonist
of the innate immune response and remarkably effects
many stages of the interferon response [62]. Two ISAV
proteins, including the putative NS protein, have been
linked to the antagonism of the IFN system [17,18], but
it was not possible to relate these functions specifically
here. In a study such as this, any viral IFN antagonistic
effect within cells is likely to go unseen due to the vast
cytokine inductions in neighbouring uninfected cells.
Real-time PCR of segment 7 followed a similar profile to
segment 8 in all three organs tested. However, correlation
analysis suggested the segment 7 load, unlike segment 8,
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pression in either the gill or the heart. This has two pos-
sible explanations. Firstly, the functions of the proteins
encoded by these segments are very different and the ex-
pression may be time dependent. In addition, the quan-
tities of the required proteins are also substantially
different and neither segment assay differentiates the two
ORFs. The M protein is the most abundant protein in the
virion [14], thus more is required compared to the non-
or minor- structural proteins encoded by segment 7.
Comparing the segment 7 to segment 8 ratios of both vi-
ruses indicated the potentially interesting observation that
HVI appears to generate less segment 7 RNA than LVI.
The significance of this is unknown and remains an area
of further investigation, although may partly explain the
lack of correlation between segment 7 and immune genes.
In conclusion, this study indicated that low virulent
ISAV (LVI) replicated earlier in the gills and dissemi-
nated throughout the host more efficiently following
immersion challenge compared to the highly virulent
virus (HVI). This suggests potential variation in tissue or
even cell tropism. Rapid replication in gills stimulated a
marked systemic immune response that may have pro-
vided some protection against LVI-induced pathogen-
esis, causing a limited infection. In contrast, the host
response against HVI was less effectual, allowing the
virus to reach a higher load causing a progressive infec-
tion and ultimately inducing significantly more mortal-
ity. Further work is required to elucidate the underlying
factors that allow LVI to replicate more efficiently in the
gills following immersion infection. Other factors such
as variable HE activity allowing increased viral particle
liberation to infect more cells, or differing abilities in im-
mune system interference may have a role to play. In
addition, because the HVI does not appear to access the
gills as quickly, other entry points such as skin, eye, gut,
should also be investigated. A greater understanding of
the molecular and pathophysiological mechanisms of
virulence and pathogenesis of LVI and HVI is critical in
developing strategies and preventative measures to com-
bat viral infection by ISAV.Additional files
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